Shares of Bath & Body Works, Inc. (NYSE:BBWI – Get Free Report) have received a consensus rating of “Moderate Buy” from the seventeen brokerages that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, six have issued a hold recommendation and ten have assigned a buy recommendation to the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $43.19.
Several research analysts have commented on the company. JPMorgan Chase & Co. lifted their target price on Bath & Body Works from $39.00 to $41.00 and gave the stock a “neutral” rating in a report on Friday, January 24th. Morgan Stanley lowered their price objective on Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a research report on Thursday, November 21st. TD Cowen upped their target price on Bath & Body Works from $42.00 to $48.00 and gave the company a “buy” rating in a report on Thursday, December 12th. Telsey Advisory Group restated an “outperform” rating and set a $42.00 price target on shares of Bath & Body Works in a report on Monday, November 25th. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on shares of Bath & Body Works from $51.00 to $52.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th.
View Our Latest Analysis on Bath & Body Works
Institutional Trading of Bath & Body Works
Bath & Body Works Price Performance
Bath & Body Works stock opened at $36.46 on Friday. The business has a 50 day moving average of $37.63 and a 200-day moving average of $33.69. The company has a market capitalization of $7.90 billion, a P/E ratio of 8.89, a P/E/G ratio of 0.90 and a beta of 1.83. Bath & Body Works has a 1 year low of $26.20 and a 1 year high of $52.99.
Bath & Body Works (NYSE:BBWI – Get Free Report) last announced its quarterly earnings results on Monday, November 25th. The company reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.46 by $0.03. The firm had revenue of $1.61 billion during the quarter, compared to analysts’ expectations of $1.58 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The company’s revenue was up 3.1% on a year-over-year basis. During the same period in the prior year, the company posted $0.48 EPS. Equities analysts anticipate that Bath & Body Works will post 3.26 EPS for the current year.
Bath & Body Works Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 7th. Stockholders of record on Friday, February 21st will be issued a dividend of $0.20 per share. The ex-dividend date is Friday, February 21st. This represents a $0.80 annualized dividend and a dividend yield of 2.19%. Bath & Body Works’s dividend payout ratio is currently 19.51%.
Bath & Body Works Company Profile
Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
See Also
- Five stocks we like better than Bath & Body Works
- How to Profit From Growth Investing
- Upstart’s Uptrend Is Just Getting Started: Its Time to Load Up
- Expert Stock Trading Psychology Tips
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- What Does Downgrade Mean in Investing?
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.